Metamizole sodiumCAS# 68-89-3 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 68-89-3 | SDF | Download SDF |
PubChem ID | 522325 | Appearance | Powder |
Formula | C13H16N3NaO4S | M.Wt | 333.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonate | ||
SMILES | CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+] | ||
Standard InChIKey | DJGAAPFSPWAYTJ-UHFFFAOYSA-M | ||
Standard InChI | InChI=1S/C13H17N3O4S.Na/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11;/h4-8H,9H2,1-3H3,(H,18,19,20);/q;+1/p-1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Metamizole sodium Dilution Calculator
Metamizole sodium Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.0003 mL | 15.0015 mL | 30.003 mL | 60.006 mL | 75.0075 mL |
5 mM | 0.6001 mL | 3.0003 mL | 6.0006 mL | 12.0012 mL | 15.0015 mL |
10 mM | 0.3 mL | 1.5002 mL | 3.0003 mL | 6.0006 mL | 7.5008 mL |
50 mM | 0.06 mL | 0.3 mL | 0.6001 mL | 1.2001 mL | 1.5002 mL |
100 mM | 0.03 mL | 0.15 mL | 0.3 mL | 0.6001 mL | 0.7501 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hydroxyzine
Catalog No.:BCC5209
CAS No.:68-88-2
- Sulfadiazine
Catalog No.:BCC3859
CAS No.:68-35-9
- Vitamin A
Catalog No.:BCN8349
CAS No.:68-26-8
- Norethindrone
Catalog No.:BCC4811
CAS No.:68-22-4
- Vitamin B12
Catalog No.:BCC4878
CAS No.:68-19-9
- Sodium citrate
Catalog No.:BCC7588
CAS No.:68-04-2
- BMS 193885
Catalog No.:BCC7613
CAS No.:679839-66-8
- N-(15-Methyl-9-hexadecenoyl)taurine
Catalog No.:BCN1754
CAS No.:679834-30-1
- N-(5,8,11,14-Eicosatetraenoyl)taurine
Catalog No.:BCN1755
CAS No.:679834-28-7
- Aurantio-obtusin
Catalog No.:BCN1222
CAS No.:67979-25-3
- Sodium Danshensu
Catalog No.:BCN5952
CAS No.:67920-52-9
- 1,6-Dihydro-4,7'-epoxy-1-methoxy-3',4'-methylenedioxy-6-oxo-3,8'-lignan
Catalog No.:BCN6584
CAS No.:67920-48-3
- Hypoxanthine
Catalog No.:BCC5324
CAS No.:68-94-0
- Ac-Pro-OH
Catalog No.:BCC3017
CAS No.:68-95-1
- Hydroxyprogesterone
Catalog No.:BCC8996
CAS No.:68-96-2
- Magnocurarine
Catalog No.:BCN3839
CAS No.:6801-40-7
- Pulsatilla saponin H
Catalog No.:BCN8181
CAS No.:68027-14-5
- Pulsatilla saponin D
Catalog No.:BCN8526
CAS No.:68027-15-6
- Carbadox
Catalog No.:BCC3744
CAS No.:6804-07-5
- (Z)-4-Hydroxytamoxifen
Catalog No.:BCC6015
CAS No.:68047-06-3
- Escin
Catalog No.:BCC8323
CAS No.:6805-41-0
- Platyconic acid A
Catalog No.:BCN3239
CAS No.:68051-23-0
- EMPA
Catalog No.:BCC6226
CAS No.:680590-49-2
- Megastigm-7-ene-3,5,6,9-tetraol
Catalog No.:BCN5169
CAS No.:680617-50-9
Effects of analgesic and noise stimulus in gait score assessment.[Pubmed:30605469]
PLoS One. 2019 Jan 3;14(1):e0208827.
This experiment was carried out aiming to assess walking manner and speed of broiler chickens with different gait scores (GS), with or without sound stimulus, and with or without administration of analgesic. To that end, 1,000 birds were evaluated by the GS test and 74 were selected for walking speed analyses. Weight at slaughter and breast yield values were obtained for comparisons. Walking speed analyses, both with and without analgesic and with and without stimulus were performed. Non-parametric statistics was applied to the GS data that did not meet the assumptions of the statistical model (normality and homogenicity) using Fisher's exact test according to the data behavior (P<0.05). The analyses of data on speed, weight at slaughter, and breast yield were evaluated by ANOVA and compared by Tukey's test (P<0.05). Walking speed differed after acoustic stimulus with or without administration of Metamizole sodium. Body weight was also different in each GS. It is thus concluded that the birds may feel discomfort when their GS is higher than 0, but that such discomfort may be suppressed when they are stimulated to walk.